BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND MSN, P26038, 4478, ENSG00000147065
44 results:

  • 1. Synergistic effect of mesoporous silica nanocarrier-assisted photodynamic therapy and anticancer agent activity on lung cancer cells.
    Güleryüz B; Işık A; Gülsoy M
    Lasers Med Sci; 2024 Mar; 39(1):91. PubMed ID: 38491201
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The inhibition of pancreatic cancer progression by K-Ras-overexpressing mesenchymal stem cell-derived secretomes.
    Huo Q; Li K; Sun X; Zhuang A; Minami K; Tamari K; Ogawa K; Fishel ML; Li BY; Yokota H
    Sci Rep; 2023 Sep; 13(1):15036. PubMed ID: 37699930
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Inhalable GSH-Triggered Nanoparticles to Treat Commensal Bacterial Infection in
    Ma Z; Wang H; Shi Z; Yan F; Li Q; Chen J; Cui ZK; Zhang Y; Jin X; Jia YG; Wang L
    ACS Nano; 2023 Mar; 17(6):5740-5756. PubMed ID: 36884352
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Glucometer Readout for Portable Detection of Heterogeneous Circulating Tumor Cells in lung cancer Captured on a Dual Aptamer Functionalized Wrinkled Cellulose Hydrogel Interface.
    Zuo Y; Lu W; Xia Y; Meng J; Zhou Y; Xiao Y; Zhu L; Liu D; Yang S; Sun Y; Li C; Yu Y
    ACS Sens; 2023 Jan; 8(1):187-196. PubMed ID: 36562728
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Efficacy and safety of immuno-chemotherapy in patients with advanced non-small-cell lung cancer harboring oncogenic mutations: a multicenter retrospective study.
    Hata T; Sakaguchi C; Hirano K; Kobe H; Ishida M; Nakano T; Tachibana Y; Tamiya N; Shiotsu S; Takeda T; Yamada T; Yokoyama T; Tsuchiya M; Nagasaka Y
    J Cancer Res Clin Oncol; 2023 Jun; 149(6):2475-2482. PubMed ID: 35737092
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A Review on Recent Technologies and Patents on Silica Nanoparticles for cancer Treatment and Diagnosis.
    Gupta A; Kushwaha SS; Mishra A
    Recent Pat Drug Deliv Formul; 2020; 14(2):126-144. PubMed ID: 32928094
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Engineering of monosized lipid-coated mesoporous silica nanoparticles for CRISPR delivery.
    Noureddine A; Maestas-Olguin A; Saada EA; LaBauve AE; Agola JO; Baty KE; Howard T; Sabo JK; Espinoza CRS; Doudna JA; Schoeniger JS; Butler KS; Negrete OA; Brinker CJ; Serda RE
    Acta Biomater; 2020 Sep; 114():358-368. PubMed ID: 32702530
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Amplification and Preparation of Cellular O-Glycomes for Functional Glycomics.
    Li Z; Zhang Q; Ashline D; Zhu Y; Lasanajak Y; Chernova T; Reinhold V; Cummings RD; Wang PG; Ju T; Smith DF; Song X
    Anal Chem; 2020 Aug; 92(15):10390-10401. PubMed ID: 32539345
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Folic acid (FA)-conjugated mesoporous silica nanoparticles combined with MRP-1 siRNA improves the suppressive effects of myricetin on non-small cell lung cancer (NSCLC).
    Song Y; Zhou B; Du X; Wang Y; Zhang J; Ai Y; Xia Z; Zhao G
    Biomed Pharmacother; 2020 May; 125():109561. PubMed ID: 32106385
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Regulation of breast cancer resistance protein and P-glycoprotein by ezrin, radixin and moesin in lung, intestinal and renal cancer cell lines.
    Yano K; Okabe C; Fujii K; Kato Y; Ogihara T
    J Pharm Pharmacol; 2020 Apr; 72(4):575-582. PubMed ID: 31975441
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. LINC00461/miR-4478/E2F1 feedback loop promotes non-small cell lung cancer cell proliferation and migration.
    Meng Q; Liu M; Cheng R
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 31934717
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Comprehensive Analysis of Aberrantly Expressed Profiles of lncRNAs and miRNAs with Associated ceRNA Network in lung Adenocarcinoma and lung Squamous Cell Carcinoma.
    Dong R; Liu J; Sun W; Ping W
    Pathol Oncol Res; 2020 Jul; 26(3):1935-1945. PubMed ID: 31898160
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Eliminating blood oncogenic exosomes into the small intestine with aptamer-functionalized nanoparticles.
    Xie X; Nie H; Zhou Y; Lian S; Mei H; Lu Y; Dong H; Li F; Li T; Li B; Wang J; Lin M; Wang C; Shao J; Gao Y; Chen J; Xie F; Jia L
    Nat Commun; 2019 Dec; 10(1):5476. PubMed ID: 31792209
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Oral glutamine supplements reduce concurrent chemoradiotherapy-induced esophagitis in patients with advanced non-small cell lung cancer.
    Chang SC; Lai YC; Hung JC; Chang CY
    Medicine (Baltimore); 2019 Feb; 98(8):e14463. PubMed ID: 30813149
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Integrating in situ formation of nanozymes with three-dimensional dendritic mesoporous silica nanospheres for hypoxia-overcoming photodynamic therapy.
    Cai X; Luo Y; Song Y; Liu D; Yan H; Li H; Du D; Zhu C; Lin Y
    Nanoscale; 2018 Dec; 10(48):22937-22945. PubMed ID: 30500027
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Extracellular matrix protein 1 recruits moesin to facilitate invadopodia formation and breast cancer metastasis.
    Wu Q; Chen D; Luo Q; Yang Q; Zhao C; Zhang D; Zeng Y; Huang L; Zhang Z; Qi Z
    Cancer Lett; 2018 Nov; 437():44-55. PubMed ID: 30165197
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Prognostic value of HLA-A2 status in advanced non-small cell lung cancer patients.
    Mezquita L; Charrier M; Faivre L; Dupraz L; Lueza B; Remon J; Planchard D; Bluthgen MV; Facchinetti F; Rahal A; Polo V; Gazzah A; Caramella C; Adam J; Pignon JP; Soria JC; Chaput N; Besse B
    Lung Cancer; 2017 Oct; 112():10-15. PubMed ID: 29191581
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Amino-functionalized mesoporous silica nanoparticles as efficient carriers for anticancer drug delivery.
    He Y; Luo L; Liang S; Long M; Xu H
    J Biomater Appl; 2017 Oct; 32(4):524-532. PubMed ID: 28776488
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Simultaneous inhibition of growth and metastasis of hepatocellular carcinoma by co-delivery of ursolic acid and sorafenib using lactobionic acid modified and pH-sensitive chitosan-conjugated mesoporous silica nanocomplex.
    Zhao R; Li T; Zheng G; Jiang K; Fan L; Shao J
    Biomaterials; 2017 Oct; 143():1-16. PubMed ID: 28755539
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A smart pH-responsive nano-carrier as a drug delivery system for the targeted delivery of ursolic acid: suppresses cancer growth and metastasis by modulating P53/MMP-9/PTEN/CD44 mediated multiple signaling pathways.
    Jiang K; Chi T; Li T; Zheng G; Fan L; Liu Y; Chen X; Chen S; Jia L; Shao J
    Nanoscale; 2017 Jul; 9(27):9428-9439. PubMed ID: 28660943
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.